Next Article in Journal
Reasonability of Frequent Laboratory Analyses during Therapy with Nivolumab and Nivolumab+Ipilimumab in Patients with Advanced or Metastatic Renal Cell Carcinoma during the Phase 2 Clinical Trial TITAN-RCC
Previous Article in Journal
Exploring miRNA Profiles in Colon Cancer: A Focus on miR101-3p, miR106a-5p, and miR326
Previous Article in Special Issue
Treatment of Pelvic and Spinal Bone Metastases: Radiotherapy and Hyperthermia Alone vs. in Combination
 
 
Article

Article Versions Notes

Cancers 2024, 16(12), 2286; https://doi.org/10.3390/cancers16122286
Action Date Notes Link
article pdf uploaded. 20 June 2024 16:22 CEST Version of Record https://www.mdpi.com/2072-6694/16/12/2286/pdf-vor
article supplementary file uploaded. 20 June 2024 16:22 CEST - https://www.mdpi.com/2072-6694/16/12/2286#supplementary
article xml file uploaded 23 June 2024 08:08 CEST Original file -
article xml uploaded. 23 June 2024 08:08 CEST Update -
article pdf uploaded. 23 June 2024 08:08 CEST Updated version of record https://www.mdpi.com/2072-6694/16/12/2286/pdf-vor
article html file updated 23 June 2024 08:09 CEST Original file -
article xml file uploaded 23 June 2024 08:15 CEST Update -
article xml uploaded. 23 June 2024 08:15 CEST Update https://www.mdpi.com/2072-6694/16/12/2286/xml
article pdf uploaded. 23 June 2024 08:16 CEST Updated version of record https://www.mdpi.com/2072-6694/16/12/2286/pdf
article html file updated 23 June 2024 08:17 CEST Update https://www.mdpi.com/2072-6694/16/12/2286/html
Back to TopTop